0 Comentários
0 Compartilhamentos
38 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Feed de notícias
- EXPLORAR
-
Páginas
-
Grupos
-
Eventos
-
Reels
-
Blogs
-
Marketplace
-
Offers
-
Jobs
-
Faça o login para curtir, compartilhar e comentar!
-
Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market – Targeted Apoptosis Therapy Advancing Oncology CareMarket Overview Cancer treatment continues to advance through therapies that restore the body's natural cell death mechanisms in malignant cells. The Bcl-2 (B-Cell Lymphoma 2) Inhibitors Market is growing as oncologists incorporate Bcl-2 inhibitor therapies into treatment regimens for hematologic malignancies where cancer cells evade normal apoptotic signaling. Hematology-oncology centers...0 Comentários 0 Compartilhamentos 590 Visualizações 0 Anterior
-
Boron Neutron Capture Therapy System Market – Targeted Radiation Approach Advancing Oncology TreatmentMarket Overview The boron neutron capture therapy system market is gaining attention as a targeted radiotherapy approach capable of selectively destroying cancer cells while sparing surrounding healthy tissue. This technique relies on boron-containing compounds accumulating preferentially in tumor cells, which are then activated by neutron irradiation to release cell-destroying particles with...0 Comentários 0 Compartilhamentos 555 Visualizações 0 Anterior
-
Cyclin Dependent Kinase Inhibitor Market – Precision Oncology Advancing Through Targeted Cell Cycle TherapyMarket Overview The cyclin dependent kinase inhibitor market is expanding rapidly as oncology shifts toward precision therapies that halt uncontrolled cell division at its source. These inhibitors block specific enzymes responsible for driving the cell cycle in cancer cells, particularly in breast cancer and other hormone-receptor-positive malignancies. Growth is fueled by rising cancer...0 Comentários 0 Compartilhamentos 500 Visualizações 0 Anterior
-
Global Histiocytic Lymphoma Treatment Market Report: Targeted Therapy, Immunotherapy and Growth ProspectsAccording to the latest report published by Data Bridge Market Research, the Histiocytic Lymphoma Treatment Market CAGR Value The global histiocytic lymphoma treatment market size was valued at USD 650.00 million in 2025 and is expected to reach USD 1,005.13 million by 2033, at a CAGR of 5.60% during the forecast period In this persuasive...0 Comentários 0 Compartilhamentos 492 Visualizações 0 Anterior
-
Growing Preference for Targeted Radiation Therapy Fuels Market DemandThe global Proton Therapy Systems Market is growing as awareness of advanced radiation therapy options increases among healthcare professionals and patients. Proton therapy may be considered for selected cancers based on tumor location, clinical evidence, and individual treatment requirements. Expanding oncology services and ongoing improvements in treatment technologies are supporting the...0 Comentários 0 Compartilhamentos 277 Visualizações 0 Anterior
-
HER2 Therapy Market Demand: Expanding Use of Targeted Therapies in HER2-Positive CancerThe HER2 therapy market is projected to grow from USD 16.8 billion in 2026 to USD 38.7 billion by 2036, registering a CAGR of 8.7%, according to Future Market Insights. The market is gaining momentum as advances in biomarker testing expand treatment eligibility and pharmaceutical companies develop targeted therapies for HER2-positive, HER2-low, and HER2-ultralow cancers. The market is expected...0 Comentários 0 Compartilhamentos 588 Visualizações 0 Anterior
-
How Rising Autoimmune Disease Prevalence and Targeted Therapy Development Are Driving the Global Ahsa1 Antibody MarketThe global Ahsa1 Antibody market is expanding as pharmaceutical companies, research institutions, and diagnostic laboratories invest in advanced antibody technologies to support therapeutic development, research applications, and diagnostic solutions. The market was valued at USD 500 million in 2024 and is projected to reach USD 1,500 million by 2035, growing at a CAGR of 10.6%. The Ahsa1...0 Comentários 0 Compartilhamentos 472 Visualizações 0 Anterior
-
How Rising Inflammatory Disease Prevalence and Targeted Therapy Development Are Driving the Global N Formyl Peptide Receptor 2 MarketThe global N Formyl Peptide Receptor 2 market is expanding as pharmaceutical companies, research institutions, and hospitals invest in advanced therapeutic solutions to address the rising incidence of inflammatory diseases, infectious diseases, and neurodegenerative disorders. The market was valued at USD 0.76 billion in 2023 and is projected to reach USD 2.0 billion by 2032, growing at a CAGR...0 Comentários 0 Compartilhamentos 429 Visualizações 0 Anterior
-
How Rising Leukemia Incidence and Targeted Therapy Advancements Are Driving the Global Hairy Cell Leukemia Treatment MarketThe global Hairy Cell Leukemia Treatment market is expanding as pharmaceutical companies, hospitals, and oncology centers invest in advanced therapeutic solutions to address the rising incidence of this rare blood cancer and improve patient survival outcomes. The market was valued at USD 850 million in 2023 and is projected to reach USD 1,650 million by 2032, growing at a CAGR of 7.7%. The...0 Comentários 0 Compartilhamentos 419 Visualizações 0 Anterior
-
Janus Kinase (JAK) Inhibitors Market – Targeted Therapy Transforming Autoimmune Disease ManagementMarket Overview The Janus kinase (JAK) inhibitors market continues to expand as targeted oral therapies increasingly replace or complement biologic injectables across rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and atopic dermatitis management. JAK inhibitors offer patients the convenience of oral dosing alongside rapid onset of action, reshaping treatment algorithms...0 Comentários 0 Compartilhamentos 527 Visualizações 0 Anterior
-
Small Molecule Targeted Cancer Therapy Market – Industry Trends and Forecast to 2030Small Molecule Targeted Cancer Therapy Market According to the latest report published by Data Bridge Market Research, the Small Molecule Targeted Cancer Therapy Market Data Bridge Market Research analyses that the global small molecule targeted cancer therapy market which was USD 75,960.00 Million in 2022, would rocket up to USD 124,772.24 Million by 2030 and is expected...0 Comentários 0 Compartilhamentos 504 Visualizações 0 Anterior
-
Oligonucleotide Therapeutics Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Oligonucleotide Therapeutics Market CAGR Value As per Data Bridge Market Research Analysis the global oligonucleotide therapeutics market size was valued at USD 30.56 billion in 2025 and is expected to reach USD 86.26 billion by 2033, at a CAGR of 13.85% during the forecast period The...0 Comentários 0 Compartilhamentos 65 Visualizações 0 Anterior
-
Pertuzumab Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Pertuzumab Market CAGR Value This Pertuzumab Marketdocument provides with CAGR value fluctuation during the forecast period for the market. The report provides wide-ranging statistical analysis of the market’s continuous positive developments, capacity, production, production value, cost/profit,...0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior
-
Rare Neurological Disease Treatment Market Competitive Landscape and Key PlayersThe global rare neurological disease treatment market is witnessing substantial growth due to increasing awareness regarding rare neurological disorders, rising investments in orphan drug development, and rapid advancements in biotechnology and precision medicine. Rare neurological diseases are complex disorders that affect the brain, spinal cord, nerves, and muscles, often leading to severe...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
-
Regional Growth Prospects for the Ovarian Cancer Drugs MarketThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Comentários 0 Compartilhamentos 2KB Visualizações 0 Anterior
Páginas impulsionada
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek